Trials / Completed
CompletedNCT02288520
Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis
Therapeutic Strategy in Rheumatology When Faced With a Patient Treated With Methotrexate (MTX) for Rheumatoid Arthritis (RA).
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 854 (actual)
- Sponsor
- Nordic Pharma SAS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a longitudinal, observational, prospective, multicentre study conducted in metropolitan France, among a representative sample of office-based or mixed practice rheumatology doctors. The aim of this study is to describe in real life, the therapy strategy when faced with a patient treated with methotrexate as a monotherapy consulting for rheumatoid arthritis and the impact on the progression of the disease at 6 months.
Conditions
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2014-11-11
- Last updated
- 2016-06-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02288520. Inclusion in this directory is not an endorsement.